Takeda: Anemia trials
The registry lists 13 Anemia studies with Takeda as lead sponsor. 4 are open to participants now and 8 have results posted.
Phase 1 1Phase 2 5Phase 3 5Phase 4 1No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking RuxolitinibRecruitingNCT07623161Phase 3
- A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood TransfusionsRecruitingNCT07422480Phase 3
- A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood TransfusionsRecruitingNCT06499285Phase 3
- A Study of Elritercept Alone or Together With Ruxolitinib in Adults With MyelofibrosisRecruitingNCT05037760Phase 2
- Evaluation of Different Dose Regimens of Aes-103 Given for 28 Days to Subjects With Stable Sickle Cell DiseaseTerminatedNCT01987908Phase 2Results posted
- Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on DialysisCompletedNCT01478971Phase 3Results posted
- Efficacy and Safety of Peginesatide Injection for the Maintenance Treatment of Anemia in Peritoneal Dialysis Participants Previously Treated With Epoetin.CompletedNCT00752791Phase 2Results posted
- Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa.CompletedNCT00752609Phase 2Results posted
- DELFT (Dynepo Evaluation of Long-Term Follow-Up Treatment)TerminatedNCT00664066Results posted
- Dynepo Long-Term Safety StudyTerminatedNCT00514813Phase 4Results posted
- Dynepo Infrequent Dosing StudyTerminatedNCT00450333Phase 3Results posted
- Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney DiseaseCompletedNCT00314795Phase 2Results posted
- A Safety and Tolerability Study of Peginesatide in Anemic Cancer Patients Receiving Cytotoxic Chemotherapy.TerminatedNCT00629876Phase 1